Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia

被引：46
|
作者：
Chu, TW
Hu, SW
Wei, B
Wang, Y
Liu, XQ
Wang, XY [1 ]
机构：
[1] Peking Univ, Coll Chem & Mol Engn, Dept Appl Chem, Beijing 100871, Peoples R China
[2] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 03期
基金：
中国国家自然科学基金;
关键词：
4-nitroimidazole; hypoxia imaging agent; biodistribution; tumor;
D O I：
10.1016/j.bmcl.2003.11.017
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
1-(4-Nitroimidazole-1-yl)-propanhydroxyiminoamide (N41PA) was synthesized. The biodistribution of Tc-99m-N41PA in mice bearing S180 tumor demonstrated that the complex showed accumulation in tumor and slow clearance from it. The tumor-to-tissue uptake ratios increase with time. These results suggest that Tc-99m-N41PA would be a marker for imaging tumor hypoxia. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码：747 / 749
页数：3
相关论文
共 50 条
  • [1] In vitro and in vivo evaluation of a Technetium-99m-labeled 4-nitroimidazole as a tracer for detection of tumor hypoxia
    Li, Nan
    Chu, Taiwei
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [2] Preparation and biological evaluation of a technetium-99m labeled 4-nitroimidazole derivative for imaging tumor hypoxia
    Xiao Lin
    Sian Fang
    Yanguo Teng
    Junbo Zhang
    Journal of Radioanalytical and Nuclear Chemistry, 2017, 313 : 39 - 45
  • [3] Preparation and biological evaluation of a technetium-99m labeled 4-nitroimidazole derivative for imaging tumor hypoxia
    Lin, Xiao
    Fang, Sian
    Teng, Yanguo
    Zhang, Junbo
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2017, 313 (01) : 39 - 45
  • [4] Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor
    Chen, Xiangji
    Li, Liang
    Liu, Fei
    Liu, Boli
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5503 - 5506
  • [5] [（99m）Tc（CO）3]+ labeled histidine derivative containing 4-nitroimidazole:Synthesis,biodistribution as a tumor hypoxia imaging agent
    MEI Lei CHU Taiwei Beijing National Laboratory for Molecular Sciences
    Nuclear Science and Techniques, 2011, 22 (02) : 105 - 110
  • [6] In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia
    Ballinger, JR
    Kee, JWM
    Rauth, AM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (06) : 1023 - 1031
  • [7] Nitroimidazoles and hypoxia imaging:: Synthesis of three Technetium-99m complexes bearing a nitroimidazole group:: Biological results
    Riché, F
    d'Hardemare, AD
    Sèpe, S
    Riou, L
    Fagret, D
    Vidal, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) : 71 - 74
  • [8] Synthesis and evaluation of two technetium-99m-labeled peptidic e-nitroimidazoles for imaging hypoxia
    Su, ZF
    Zhang, XG
    Ballinger, JR
    Rauth, AM
    Pollak, A
    Thornback, JR
    BIOCONJUGATE CHEMISTRY, 1999, 10 (05) : 897 - 904
  • [9] Technetium-99m-labeled lapachol as an imaging probe for breast tumor identification
    Miranda, S. E.
    Lemos, J. A.
    Fernandes, R. S.
    Ottoni, F. M.
    Alves, R. J.
    Ferretti, A.
    Rubello, D.
    Cardoso, V. N.
    Branco de Barros, A. L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (03): : 167 - 172
  • [10] Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates
    Ultee, ME
    Bridger, GJ
    Abrams, MJ
    Longley, CB
    Burton, CA
    Larsen, SK
    Henson, GW
    Padmanabhan, S
    Gaul, FE
    Schwartz, DA
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (01) : 133 - 138
12345